Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Saudi Medical Journal. 2006; 27 (1): 52-57
Dans Anglais | IMEMR | ID: emr-80568

Résumé

To investigate the incidence, risk factors and the etiology of ventilator-associated pneumonia [VAP] in surgical emergency intensive care unit [ICU] patients. We conducted this prospective cohort study in the surgical emergency ICU of Istanbul Medical Faculty between December 1999 and May 2001. We included 100 mechanically ventilated patients in this study. We diagnosed VAP according to the current diagnostic criteria. We identified the etiology of VAP cases by both quantitative cultures of endotracheal aspiration and blood cultures. To analyze the predisposing factors for the development of VAP, we recorded the following variables: age, gender, acute physiology and chronic health evaluation [APACHE] II score, Glasgow coma scale [GCS], sequential organ failure assessment [SOFA] score, serum albumin level, duration of mechanical ventilation [MV] prior to the development of VAP, and underlying diseases. We determined the VAP incidence rate as 28%. We found the APACHE II score and the duration of MV to be statistically significant variables for the development of VAP. There were no significant differences regarding age, gender, GCS, SOFA score, albumin level, or underlying diseases for the development of VAP. The isolated bacteria among VAP cases were as follows: Staphylococcus aureus [n=12, 43%], Acinetobacter spp. [n=6, 21%], coagulase-negative Staphylococci [n=4, 15%], Pseudomonas aeruginosa [n=3, 10.7%] and Klebsiella pneumoniae [n=3, 10.7%]. Ventilator-associated pneumonia is a common infection, and certain interventions might affect the incidence of VAP. The ICU clinicians should be aware of the risk factors for VAP, which could prove useful in identifying patients at high risk for VAP, and modifying patient care to minimize the risk of VAP


Sujets)
Humains , Mâle , Femelle , Pneumopathie infectieuse/étiologie , Pneumopathie infectieuse/épidémiologie , Unités de soins intensifs , Durée du séjour , Infection croisée , Facteurs de risque , Polytraumatisme/mortalité , Analyse de survie , Ventilation artificielle/effets indésirables , Études prospectives , Études de cohortes
SÉLECTION CITATIONS
Détails de la recherche